Drug
Firsocostat clinical trials
Also written GS-0976.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Cilofexor (4) · Selonsertib (2) · Semaglutide (1) · Fenofibrate (1)
Studies
Open first, then newest update. How each study uses firsocostat is read from its arms, and is right about nine times in ten.
Testing it · 7
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Gilead SciencesNCT04971785Written as Cilofexor (CILO)/Firsocostat (FIR)
- Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Gilead SciencesNCT02781584Written as FIR
- Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Gilead SciencesNCT03987074Written as Firsocostat
- Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic FunctionCompletedPhase 1Gilead SciencesNCT02891408Written as Firsocostat
- Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)CompletedPhase 2Gilead SciencesNCT03449446Written as FIR
- Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic SteatohepatitisCompletedPhase 2Gilead SciencesNCT02856555Written as Firsocostat
- Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult SubjectsCompletedPhase 1Gilead SciencesNCT02876796Written as GS-0976
Codes
What other systems call firsocostat · ClinicalTrials.gg INT001014
- MeSH (NLM) C000629250firsocostatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) XE10NJQ95MFIRSOCOSTATConfirmed FDA, NLM
- NCI Thesaurus C169983FirsocostatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629250 | firsocostat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | XE10NJQ95M | FIRSOCOSTAT | Confirmed FDA, NLM |
| NCI Thesaurus | C169983 | Firsocostat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.